Evidence Based Medicine on FHIR Implementation Guide
1.0.0-ballot3 - STU 1 Ballot 3 World

Evidence Based Medicine on FHIR Implementation Guide, published by HL7 International / Clinical Decision Support. This guide is not an authorized publication; it is the continuous build for version 1.0.0-ballot3 built by the FHIR (HL7® FHIR® Standard) CI Build. This version is based on the current content of https://github.com/HL7/ebm/ and changes regularly. See the Directory of published versions

EvidenceVariable: OutcomeDefinition: Diabetic ketoacidosis

Computable Name:

version: 70; Last updated: 2026-08-06 17:15:59+0000

ArtifactPublicationStatus: Active

url: https://fevir.net/resources/EvidenceVariable/236971

identifier: FEvIR Object Identifier/236971, FEvIR Linking Identifier/MAGIC-5288-j1Wqrn-313962, outcomeId/313962, picoId/85798, sectionId/73215

name: Diabetic_ketoacidosis313962

title: OutcomeDefinition: Diabetic ketoacidosis

shortTitle: Diabetic ketoacidosis

citeAs:

OutcomeDefinition: Diabetic ketoacidosis [Database Entry: FHIR EvidenceVariable Resource]. Contributors: Computable Publishing®: MAGIC-to-FEvIR Converter [Authors/Creators]. In: Fast Evidence Interoperability Resources (FEvIR) Platform, FOI 236971. Revised 2026-08-06. Available at: https://fevir.net/resources/EvidenceVariable/236971. Computable resource at: https://fevir.net/resources/EvidenceVariable/236971#json.

status: Active

author: Computable Publishing®: MAGIC-to-FEvIR Converter:

publisher: Computable Publishing LLC

contact: support@computablepublishing.com

description:

Diabetic ketoacidosis

copyright:

Copyright the Authors else Computable Publishing LLC. Noncommercial use permitted with CC BY-NC-SA 4.0 (https://creativecommons.org/licenses/by-nc-sa/4.0/). Commercial use permitted as agreed in Terms of Use (https://fevir.net/termsofuse).

RelatesTos

-TypeTarget[x]
*Part OfMAGICapp Conversion Report: SGLT2 inhibitors and GLP-1 RA for type 2 diabetes (Identifier: FEvIR Linking Identifier/MAGIC-5288-j1Wqrn-conversion-report)

Definitions

-Concept
*Diabetic ketoacidosis

handling: dichotomous variable